BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer

Journal:

Journal of Clinical Investigation

Published:

2025-06-24

DOI:

10.1172/jci180378

Affiliations:

7

Authors:

21

Go to article

Institutions	Authors	Share
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA)	10.000000 10.000000	0.48
University of Washington (UW), United States of America (USA)	3.000000	0.14
Weill Cornell Medicine, United States of America (USA)	3.000000	0.14
Zenith Epigenetics Corp., Canada	2.000000	0.10
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	2.000000	0.10
Triana Biomedicines Inc., United States of America (USA)	1.000000	0.05

Interested in Oncology and Carcinogenesis?